Medical News Podcast cover art

Medical News Podcast

Medical News Podcast

Written by: PeerDirect
Listen for free

The Medical News Podcast by PeerDirect delivers news and interviews with clinical thought leaders and researchers to keep you informed of the latest breakthroughs, guidelines, and insights in your specialty. Designed for clinicians with stories selected by the PeerDirect editorial board. Visit us at peerdirect.com to sign-up for our newsletter.Copyright © 2024 PeerDirect Publishing Biological Sciences Hygiene & Healthy Living Physical Illness & Disease Science
Episodes
  • How easy is it to get prescription GLP-1s online?
    Jul 16 2026
    This episode reviews new evidence on online GLP-1 prescribing practices, aspirin-only thromboprophylaxis after hip and knee arthroplasty, unexpected protection against gonorrhea from meningococcal B vaccination, and a cannabinoid formulation for agitation in advanced dementia. The studies highlight evolving approaches to obesity care, postoperative management, infectious disease prevention, and palliative dementia treatment with important implications for clinical practice.
    Show More Show Less
    6 mins
  • Approaches to Pharmacotherapy in ILD, IPF, and PPF
    Jul 15 2026
    Drs. Martinez and Montesi discuss how treatment for ILD, IPF, and PPF has shifted from “nothing we can do” to a complex, rapidly expanding toolbox that now includes multiple antifibrotic options and emerging combination strategies. They stress that these drugs slow progression but don’t cure disease, so real-world decisions hinge on side effects, quality of life considerations, patient goals, and the often frustrating realities of insurance coverage and cost.
    Show More Show Less
    13 mins
  • Can two common ICU treatments actually do more harm than good?
    Jul 9 2026
    Randomized evidence suggests that routinely used mucoactive therapies may no longer have a role in mechanically ventilated ICU patients, while a large comparative effectiveness study indicates GLP-1 receptor agonists may offer superior cardiovascular and atrial fibrillation outcomes compared with SGLT2 inhibitors in patients with both AF and type 2 diabetes. We also highlight a promising blood-based RNA biomarker panel that may predict Alzheimer's symptom onset several years before cognitive decline, potentially improving patient selection for emerging disease-modifying therapies.
    Show More Show Less
    5 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet